Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02436772 · ClinicalTrials.gov registry record
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
A clinical trial, sponsored by SCRI Development Innovations.
- Completed
- Registry status
- 74
- Enrollment target
NCT02436772 is a clinical trial that has completed, run by SCRI Development Innovations. The registered enrollment target is 74 participants.
The verdict
NCT02436772 has completed, sponsored by SCRI Development Innovations.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
This study evaluates the performance of a blood test for detecting biomarkers in metastatic breast cancer patients at one clinic against standard testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2015-05-13 |
| Est. Completion | 2017-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02436772
The ClinicalTrials.gov registry entry for NCT02436772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SCRI Development Innovations, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02436772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02436772 about?
NCT02436772 is a clinical study titled "Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC". This study evaluates the performance of a blood test for detecting biomarkers in metastatic breast cancer patients at one clinic against standard testing.
What is the current status of trial NCT02436772?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2015-05-13. Estimated completion is 2017-07-07.
Who is sponsoring clinical trial NCT02436772?
This trial is sponsored by SCRI Development Innovations, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.